Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (20547) 20547
Newspaper Article (382) 382
Book Chapter (56) 56
Book / eBook (21) 21
Magazine Article (16) 16
Publication (6) 6
Dissertation (4) 4
Trade Publication Article (3) 3
Government Document (2) 2
Book Review (1) 1
Conference Proceeding (1) 1
Newsletter (1) 1
Patent (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (18374) 18374
humans (17971) 17971
life sciences & biomedicine (15417) 15417
female (10163) 10163
human papillomavirus (7090) 7090
immunology (6602) 6602
adult (5702) 5702
oncology (4985) 4985
male (4941) 4941
cancer (4659) 4659
middle aged (4576) 4576
cervical cancer (4426) 4426
animals (4153) 4153
biological and medical sciences (4124) 4124
infectious diseases (3771) 3771
vaccines (3770) 3770
papillomavirus infections (3471) 3471
medical sciences (3418) 3418
tumors (3358) 3358
health aspects (3324) 3324
research article (3200) 3200
research (2999) 2999
medicine (2988) 2988
science & technology - other topics (2974) 2974
multidisciplinary sciences (2929) 2929
adolescent (2894) 2894
vaccination (2881) 2881
microbiology (2861) 2861
aged (2734) 2734
infections (2572) 2572
viruses (2568) 2568
proteins (2562) 2562
virology (2518) 2518
risk factors (2503) 2503
analysis (2496) 2496
science (2476) 2476
medicine, research & experimental (2278) 2278
research & experimental medicine (2277) 2277
young adult (2235) 2235
papillomavirus infections - virology (2066) 2066
papillomavirus infections - prevention & control (2058) 2058
immunization (2045) 2045
mice (1940) 1940
uterine cervical neoplasms - virology (1825) 1825
gene expression (1757) 1757
cell biology (1738) 1738
deoxyribonucleic acid--dna (1721) 1721
medical research (1699) 1699
viral diseases (1530) 1530
genetic aspects (1514) 1514
immunotherapy (1499) 1499
studies (1463) 1463
virus diseases (1461) 1461
papillomavirus infections - epidemiology (1457) 1457
child (1423) 1423
pathology (1423) 1423
squamous cell carcinoma (1413) 1413
papillomaviridae - genetics (1394) 1394
cervix (1389) 1389
hpv (1388) 1388
papillomaviruses (1385) 1385
fundamental and applied biological sciences. psychology (1380) 1380
care and treatment (1369) 1369
epidemiology (1355) 1355
uterine cervical neoplasms - prevention & control (1345) 1345
dna (1306) 1306
papillomavirus infections - complications (1305) 1305
allergy and immunology (1298) 1298
womens health (1292) 1292
antigens (1275) 1275
papillomavirus vaccines - immunology (1262) 1262
papillomavirus infections - immunology (1251) 1251
public health (1230) 1230
hiv (1228) 1228
papillomaviridae - immunology (1227) 1227
biology (1226) 1226
polymerase chain reaction (1214) 1214
prevention (1204) 1204
diagnosis (1192) 1192
papillomavirus vaccines - administration & dosage (1165) 1165
medicine and health sciences (1157) 1157
biology and life sciences (1131) 1131
human immunodeficiency virus--hiv (1121) 1121
cell line, tumor (1110) 1110
development and progression (1109) 1109
papillomaviridae - isolation & purification (1102) 1102
immune response (1083) 1083
abridged index medicus (1058) 1058
prognosis (1048) 1048
apoptosis (1040) 1040
biochemistry & molecular biology (1039) 1039
patients (1019) 1019
dermatology (1016) 1016
immune system (1002) 1002
prevalence (1002) 1002
aged, 80 and over (1001) 1001
biotechnology & applied microbiology (993) 993
mutation (991) 991
uterine cervical neoplasms - pathology (977) 977
immunohistochemistry (961) 961
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (20936) 20936
German (48) 48
Portuguese (43) 43
French (36) 36
Japanese (35) 35
Chinese (28) 28
Spanish (19) 19
Russian (17) 17
Polish (9) 9
Norwegian (5) 5
Czech (4) 4
Hungarian (4) 4
Bulgarian (2) 2
Dutch (2) 2
Hebrew (2) 2
Turkish (2) 2
Ukrainian (2) 2
Croatian (1) 1
Icelandic (1) 1
Italian (1) 1
Persian (1) 1
Romanian (1) 1
Serbian (1) 1
Slovenian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Human papillomavirus and cervical cancer
by Crosbie, Emma J, PhD and Einstein, Mark H, MD and Franceschi, Silvia, MD and Kitchener, Henry C, Prof
The Lancet (British edition), ISSN 0140-6736, 2013, Volume 382, Issue 9895, pp. 889 - 899
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Gynecology. Andrology. Obstetrics | General aspects | Infectious diseases | Viral diseases | Biological and medical sciences | Medical sciences | Female genital diseases | Tumors | Human papillomavirus 18 - immunology | Human papillomavirus 6 - immunology | Humans | Uterine Cervical Neoplasms - epidemiology | Human papillomavirus 11 - ultrastructure | Uterine Cervical Neoplasms - pathology | Human papillomavirus 16 - immunology | Human papillomavirus 6 - ultrastructure | Papillomavirus Infections - pathology | Papillomavirus Infections - immunology | Female | Papillomavirus Infections - virology | Human papillomavirus 11 - immunology | Human papillomavirus 16 - ultrastructure | Human papillomavirus 11 - pathogenicity | Papillomavirus Vaccines - administration & dosage | Human papillomavirus 6 - pathogenicity | Human papillomavirus 16 - pathogenicity | Cross-Sectional Studies | Papillomavirus Infections - epidemiology | Uterine Cervical Neoplasms - prevention & control | Uterine Cervical Neoplasms - immunology | Vaginal Smears | Mass Screening | Virus Replication | Human papillomavirus 18 - pathogenicity | Papillomavirus Infections - prevention & control | Uterine Cervical Neoplasms - virology | Human papillomavirus 18 - ultrastructure | Papillomavirus Vaccines - immunology | Developing Countries | Cell Transformation, Neoplastic - pathology | Cell Transformation, Viral | Prevention | Papillomaviruses | Usage | Vaccines | Properties | Papillomavirus infections | Risk factors | Cervical cancer | Studies | Human papillomavirus | Immunization | Cellular biology | Womens health | Medical screening | Epidemiology | Age | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial
by Trimble, Cornelia L, Prof and Morrow, Matthew P, PhD and Kraynyak, Kimberly A, PhD and Shen, Xuefei, PhD and Dallas, Michael, PhD and Yan, Jian, PhD and Edwards, Lance, MD and Parker, R Lamar, MD and Denny, Lynette, MD and Giffear, Mary, BS and Brown, Ami Shah, PhD and Marcozzi-Pierce, Kathleen, MA and Shah, Divya, MS and Slager, Anna M, MS and Sylvester, Albert J, MS and Khan, Amir, PhD and Broderick, Kate E, PhD and Juba, Robert J, MSCEP and Herring, Timothy A, MPH and Boyer, Jean, PhD and Lee, Jessica, MPH and Sardesai, Niranjan Y, PhD and Weiner, David B, Prof and Bagarazzi, Mark L, MD
The Lancet (British edition), ISSN 0140-6736, 2015, Volume 386, Issue 10008, pp. 2078 - 2088
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Human papillomavirus 18 - immunology | Humans | Papillomavirus E7 Proteins - immunology | Vaccines, DNA - immunology | Cervical Intraepithelial Neoplasia - drug therapy | Human papillomavirus 16 - immunology | Papillomavirus E7 Proteins - genetics | Young Adult | Cancer Vaccines - therapeutic use | Adult | Female | Oncogene Proteins, Viral - genetics | Papillomavirus Infections - virology | Human papillomavirus 18 - genetics | DNA-Binding Proteins - immunology | Papillomavirus Vaccines - therapeutic use | Double-Blind Method | Repressor Proteins - genetics | Treatment Outcome | Uterine Cervical Neoplasms - drug therapy | Vaccines, DNA - therapeutic use | DNA-Binding Proteins - genetics | Cervical Intraepithelial Neoplasia - virology | Cancer Vaccines - immunology | Repressor Proteins - immunology | Papillomavirus Infections - drug therapy | Uterine Cervical Neoplasms - virology | Papillomavirus Vaccines - immunology | Oncogene Proteins, Viral - immunology | Human papillomavirus 16 - genetics | Proteins | Cervix dysplasia | DNA | Clinical trials | Product development | Vaccines | Health aspects | Papillomavirus infections | Medical research | Analysis | Medicine, Experimental | Human papillomavirus | Immunization | Womens health | Immunotherapy | Genomes | Cervical cancer | Deoxyribonucleic acid--DNA | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Efficacy of the human papillomavirus (HPV)‐16/18 AS04‐adjuvanted vaccine in women aged 15–25 years with and without serological evidence of previous exposure to HPV‐16/18
by Szarewski, A and Poppe, W.A.J and Skinner, S.R and Wheeler, C.M and Paavonen, J and Naud, P and Salmeron, J and Chow, S.‐N and Apter, D and Kitchener, H and Castellsagué, X and Teixeira, J.C and Hedrick, J and Jaisamrarn, U and Limson, G and Garland, S and Romanowski, B and Aoki, F.Y and Schwarz, T.F and Bosch, F.X and Harper, D.M and Hardt, K and Zahaf, T and Descamps, D and Struyf, F and Lehtinen, M and Dubin, G and HPV PATRICIA Study Grp and HPV PATRICIA Study Group and for the HPV PATRICIA Study Group
International journal of cancer, ISSN 0020-7136, 07/2012, Volume 131, Issue 1, pp. 106 - 116
vaccine efficacy against human papillomavirus‐16/18 | human papillomavirus‐18 | previous exposure | human papillomavirus‐16 | human papillomavirus vaccines | human papillomavirus-16 | vaccine efficacy against human papillomavirus-16/18 | human papillomavirus-18 | Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Infectious diseases | Medical sciences | Viral diseases | Tumors | Cervical Intraepithelial Neoplasia - pathology | Human papillomavirus 18 - immunology | Adjuvants, Immunologic | Humans | Vaccination | Treatment Outcome | Human papillomavirus 16 - immunology | Antibodies, Viral - blood | DNA, Viral - blood | Papillomavirus Infections - pathology | Young Adult | Papillomavirus Infections - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Papillomavirus Infections - immunology | Papillomavirus Vaccines - adverse effects | Adult | Female | Papillomavirus Infections - virology | Papillomavirus Vaccines - immunology | Papillomavirus Vaccines - administration & dosage | Cohort Studies | Confidence intervals | Human papillomavirus | Immunization | Infections | Vaccines | Deoxyribonucleic acid--DNA | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Natural History of Genital Warts: Analysis of the Placebo Arm of 2 Randomized Phase III Trials of a Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Vaccine
by Suzanne M. Garland and Marc Steben and Heather L. Sings and Margaret James and Shuang Lu and Radha Railkar and Eliav Barr and Richard M. Haupt and Elmar A. Joura
The Journal of infectious diseases, ISSN 0022-1899, 3/2009, Volume 199, Issue 6, pp. 805 - 814
Polymerase chain reaction | Vaccination | Human papillomavirus 11 | Condylomata acuminata | Human papillomavirus 6 | Placebos | Antibodies | Viruses | Infections | Lesions | Genotypes | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Fundamental and applied biological sciences. Psychology | Miscellaneous | Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) | Infectious diseases | Applied microbiology | Viral diseases of the genital and urinary system | Viral diseases | Biological and medical sciences | Medical sciences | Human viral diseases | Virology | Human papillomavirus 18 - immunology | Follow-Up Studies | Human papillomavirus 6 - immunology | Humans | Papillomavirus Infections - epidemiology | Risk Factors | Human papillomavirus 6 - genetics | Condylomata Acuminata - epidemiology | Genotype | Human papillomavirus 16 - immunology | Randomized Controlled Trials as Topic | Viral Vaccines - administration & dosage | Young Adult | Clinical Trials, Phase III as Topic | Time Factors | Condylomata Acuminata - immunology | Papillomavirus Infections - prevention & control | Adolescent | Papillomavirus Infections - immunology | Adult | Female | Human papillomavirus 18 - genetics | Human papillomavirus 16 - genetics | Clinical trials | Development and progression | Reports | Condyloma acuminatum | Research | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Assessment of herd effects among women and heterosexual men after girls-only HPV16/18 vaccination in the Netherlands: A repeated cross-sectional study
by Woestenberg, P.J and Bogaards, Johannes and King, A.J and Leussink, S and Sande, Marianne and Hoebe, Christian and Med Microbiological Labs Public Hl and Medical Microbiological Laboratories and the Public Health Services and on behalf of the Medical Microbiological Laboratories and the Public Health Services
International journal of cancer, ISSN 0020-7136, 11/2018, Volume 144, Issue 11, pp. 2718 - 2727
herd protection | population effects | public health | human papillomavirus | vaccination | Life Sciences & Biomedicine | Oncology | Science & Technology | Human papillomavirus 18 - immunology | Prevalence | Humans | Mass Vaccination - statistics & numerical data | Netherlands - epidemiology | Male | Sexually Transmitted Diseases - epidemiology | Human papillomavirus 16 - immunology | Sexually Transmitted Diseases - prevention & control | Mass Vaccination - methods | Young Adult | Papillomavirus Infections - immunology | Adult | Female | Papillomavirus Infections - virology | Papillomavirus Vaccines - administration & dosage | Outcome Assessment, Health Care - statistics & numerical data | Cross-Sectional Studies | Sexually Transmitted Diseases - virology | Papillomavirus Infections - epidemiology | Sexually Transmitted Diseases - immunology | Uterine Cervical Neoplasms - prevention & control | Uterine Cervical Neoplasms - immunology | Papillomavirus Infections - prevention & control | Adolescent | Uterine Cervical Neoplasms - virology | Papillomavirus Vaccines - immunology | Program Evaluation | Women | Medicine, Experimental | Medical research | Sexually transmitted diseases | Analysis | Vaccination | Human papillomavirus | Immunization | Sexually transmitted diseases--STD | Vaccines | Girls | Index Medicus | Infectious Causes of Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 vaccine and HPV-6/11/16/18 vaccine
: Follow-up from Months 12-24 in a Phase III randomized study of healthy women aged 18-45 years
by Einstein, Mark H and Baron, Mira and Levin, Myron J and Chatterjee, Archana and Fox, Bradley and Scholar, Sofia and Rosen, Jeffrey and Chakhtoura, Nahida and Meric, Dorothée and Dessy, Francis J and Datta, Sanjoy Kumar and Descamps, Dominique and Dubin, Gary and HPV-010 Study Grp and HPV-010 Study Group
Human vaccines, ISSN 1554-8600, 12/2011, Volume 7, Issue 12, pp. 1343 - 1358
Immunology | Life Sciences & Biomedicine | Biotechnology & Applied Microbiology | Science & Technology | Human papillomavirus 18 - immunology | Follow-Up Studies | Human papillomavirus 6 - immunology | Humans | Middle Aged | Human papillomavirus 16 - immunology | Antibodies, Viral - blood | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | CD4-Positive T-Lymphocytes - immunology | Young Adult | Papillomaviridae - immunology | Papillomavirus Infections - immunology | Papillomavirus Vaccines - adverse effects | Adult | Female | Papillomavirus Infections - virology | Papillomavirus Vaccines - administration & dosage | Uterine Cervical Neoplasms - prevention & control | Uterine Cervical Neoplasms - immunology | Treatment Outcome | Papillomavirus Infections - prevention & control | Adolescent | Papillomavirus Vaccines - immunology | Antibodies, Neutralizing - blood | Cohort Studies | Index Medicus | Research Paper | Gardasil | safety | immunogenicity | human papillomavirus | Cervarix
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Antigenic Peptide Prediction From E6 and E7 Oncoproteins of HPV Types 16 and 18 for Therapeutic Vaccine Design Using Immunoinformatics and MD Simulation Analysis
by Jabbar, Basit and Rafique, Shazia and Salo-Ahen, Outi M H and Ali, Amjad and Munir, Mobeen and Idrees, Muhammad and Mirza, Muhammad Usman and Vanmeert, Michiel and Shah, Syed Zawar and Jabbar, Iqra and Rana, Muhammad Adeel
Frontiers in immunology, ISSN 1664-3224, 2018, Volume 9, pp. 3000 - 3000
binding affinity | docking | epitope prediction | human papillomavirus | MHC-I | peptide vaccine | computational | Life Sciences & Biomedicine | Immunology | Science & Technology | Human papillomavirus 18 - immunology | Antigens, Viral - metabolism | Oncogene Proteins, Viral - chemistry | Epitopes, B-Lymphocyte - chemistry | Humans | Papillomavirus E7 Proteins - immunology | Epitopes, B-Lymphocyte - immunology | Human papillomavirus 16 - immunology | DNA-Binding Proteins - metabolism | Histocompatibility Antigens Class I - metabolism | Papillomavirus Infections - immunology | Epitope Mapping - methods | Female | Papillomavirus Infections - virology | Epitopes, T-Lymphocyte - immunology | Repressor Proteins - metabolism | Oncogene Proteins, Viral - metabolism | Computational Biology - methods | Repressor Proteins - chemistry | DNA-Binding Proteins - immunology | Vaccines, Subunit - chemistry | Histocompatibility Antigens Class I - immunology | Uterine Cervical Neoplasms - prevention & control | Uterine Cervical Neoplasms - immunology | Antigens, Viral - chemistry | Vaccines, Subunit - immunology | Histocompatibility Antigens Class I - chemistry | DNA-Binding Proteins - chemistry | Molecular Dynamics Simulation | Epitopes, T-Lymphocyte - chemistry | Antigens, Viral - immunology | Papillomavirus E7 Proteins - metabolism | Papillomavirus Vaccines - chemistry | Papillomavirus Infections - prevention & control | Repressor Proteins - immunology | Epitopes, B-Lymphocyte - metabolism | Uterine Cervical Neoplasms - virology | Papillomavirus E7 Proteins - chemistry | Papillomavirus Vaccines - immunology | Oncogene Proteins, Viral - immunology | Structural Homology, Protein | Epitopes, T-Lymphocyte - metabolism | Molecular simulation | Usage | Care and treatment | Peptides | Research | Gene expression | Papillomavirus infections | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights